Wednesday, 5 October 2016

Global Hematopoietic Stem Cells Transplantation Market Is Expected To Reach USD 7,796.1 Mn By 2022 – Credence Research

The latest market report published by Credence Research, Inc. “Global Hematopoietic Stem Cells Transplantation Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the hematopoietic stem cells transplantation market was valued at USD 3,741.3 Mn in 2015, and is expected to reach USD 7,796.1 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Market Insights
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Browse the full report Hematopoietic Stem Cells Transplantation Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report athttp://www.credenceresearch.com/report/hematopoietic-stem-cells-transplantation-market
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
Market Competition Assessment:
The hematopoietic stem cells transplantation market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH,   Cesca Therapeutics Inc.,  R&D Systems, Genlantis, Lonza Group Ltd., TiGenix N.V., and ScienCell Research Laboratories.
Key Market Movements:
  • Rising prevalence of leukemia is expected to assist the hematopoietic stem cells transplantation as the survival rates in leukemia patients has been improved after HSCT.
  • Future opportunity for HSCT market lies in regenerative Stromal Cell Therapy because it is considered as one of the novel therapies for prevention and treatment of acute graft versus host disease in allogeneic HSCT patients.
  • In emerging economies growing government support through providing favorable environments for research laboratories in the field of stem cell research
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Clinical Laboratory Services Market is expected to reach USD 248.5 Mn by 2022, Credence Research

The latest market report published by Credence Research, Inc. “Global Clinical Laboratory Services Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the clinical laboratory services market was valued at USD 165.8 Bn in 2015, and is expected to reach USD 248.5 Mn by 2022, expanding at a CAGR of 5.9% from 2016 to 2022.
Market Insights
The clinical diagnostic tests performed by laboratories can be broadly classified into four major categories, namely, clinical chemistry, medical microbiology & cytology, human and tumor genetics and other esoteric tests. Ranging from routine blood and urine tests to high-end genetic analysis including fluorescence in situ hybridization (FISH), molecular expression testing, etc., clinical laboratories offer numerous tests that help detect disease progression and abnormalities. The three major types of service providers in this market include hospital-based laboratories, clinic-based laboratories and stand-alone laboratories. With the increasing incidence rates of debilitating conditions such as cancer, diabetes and infectious diseases, the number of patients that will opt for such tests will continue to increase in the future and thereby increase the demand for these services.
Browse the full report Clinical Laboratory Services Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report athttp://www.credenceresearch.com/report/clinical-laboratory-services-market
Moreover, the percentage of aged population in the U.S. is expected to grow to an estimated 20% by 2030. Such a large population of elderly people in the U.S. alone will lead to high testing volumes for clinical laboratories. Diagnostics manufacturers such as Roche Holdings, Genomic Health, Abbott Diagnostics, Qiagen, etc. are focusing their efforts towards developing products and systems that would enable highly accurate analysis of patient samples and also enable processing of thousands of samples at a time. This will help clinical laboratories to cope with the rising demand and in turn ensure revenue generation.
Market Competition Assessment:
The clinical laboratory services market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Abbott Laboratories, ARUP Laboratories, Bio-Reference Laboratories, Bioscientia Healthcare, Charles River Laboratories, Genoptix Medical Laboratory, Healthscope, Laboratory Corporation Of America Holdings (Labcorp), Labco S.A., Sonic Healthcare Limited, Spectra Laboratories, Quest Diagnostics, Inc., Genzyme Corporation, and Siemens.
Key Market Movements:
  • Specialized diagnostic tests have aided early disease detection which has assisted the overall growth of clinical laboratory services market
  • In clinical laboratory services market Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to presence of high unmet medical needs coupled with rapidly improving healthcare infrastructure in the emerging markets of India and China are some key drivers of this region
  • The independent laboratories sector is dominated by two players, Quest Diagnostics and Lab Corp, with about half the share
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Global Hybrid Operating Room Market is expected to reach USD 9.7 Bn by 2022, Credence Research

According to the latest report published by Credence Research, Inc. “Hybrid Operating Room Market – (Device Type – Operating Tables, Lighting Systems, Surgical Beams, Surgical Imaging Displays, Intraoperative Diagnostic Devices and Operating Room Communication Systems; Application Type –  Therapeutic: Cardiovascular Surgeries, Neurosurgery, Thoracic Surgery, Biopsy, Orthopedic Surgeries, Laparoscopic Surgeries, Emergency Care And Other Surgeries, Diagnostics: Fluoroscopy, Digital Subtraction Angiography, And 3D C-Arm Computer Tomography; End User – Hospitals, Clinics, Medical Research Institute And Ambulatory Surgical Centers) :Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  market was valued at USD 3.4 Bn in 2015, and is expected to reach USD 9.7 Bn by 2022, expanding at a CAGR of 16.1% from 2016 to 2022.
Browse the full report Hybrid Operating Room Market: Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/hybrid-operating-room-market
Market Insights
Hybrid operating rooms are extremely complex working environments where a large team of surgeons, interventionalists, nurses, anesthesiologists, and technicians need to work seamlessly together. A hybrid OR (Operating Room) is an alternative to conventional OR equipped with advanced medical imaging systems and devices supporting high quality interventional imaging and minimally invasive surgeries.  North America held the largest regional market, accounting for the market share of over 37.3% in 2015, and is anticipated to dominate the global hybrid operating room market during the forecast period of 2016 to 2022. Rising number of hybrid operating room facilities and higher acceptance of technology are the key factors driving the North America hybrid operating room market. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to rising medical tourism in the region, growing medical investments and healthcare infrastructure in Asia Pacific.
Among the devices types, intraoperative diagnostic devices held the largest share in the global hybrid operating room market due to its wider application in the cardiovascular and neurosurgery.  Moreover, rising minimally invasive surgeries would further enhance the application of intraoperative diagnostic devices driving the market further.
The therapeutic application held the largest share in the global hybrid operating room market. The cardiovascular surgeries dominated the therapeutic application segment owing to the rise in the prevalence of cardiovascular diseases worldwide.  The diagnostic imaging is anticipated to exhibit fastest growth rate in the hybrid operating room market. Rising number of minimally invasive surgery and robotic surgery to drive the diagnostic imaging market.
Hospitals held the largest share in the end user segment of the global hybrid operating room market. Rising number of hospitals coming up with hybrid operating room is the major factor driving the hybrid operating room market. Clinics are expected to be the fastest growing end user segment in the global hybrid operating room market.

Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Medical Gases Market is expanding at a CAGR of 8.3% from 2016 to 2022, Credence Research

According to the latest report published by Credence Research, Inc. “Global Medical Gases (Pure Medical Gases, Medical Gas Mixtures and Medical Gas Equipment) Market – Growth, Future Prospects and Competitive Assessment, 2016 – 2022,” the medical gases market was valued at USD 6,996.4 Mn in 2015, and is expected to reach USD 12,166.1 Mn by 2022, expanding at a CAGR of 8.3% from 2016 to 2022.
Market Insights                                                  
Technological advancements in the area of medical gases administration, expansion in emerging countries, high prevalence of chronic diseases that demand use of medical gases in disease management are the key trends currently witnessed in the medical gases market. Growing prevalence of geriatric population, that exhibit compromised immunity and higher susceptibility towards respiratory diseases is a key driver of medical gases market. Conversely restricted reimbursements to respiratory therapies may hold back the growth of medical gases market.
Browse the full report Global Medical Gases Market – Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/medical-gases-market
This report studies the medical devices market in terms of products, end-uses and geographic distribution. Pure medical gases, medical gas mixtures and medical gas equipment are the three major product categories in medical gases market. These sections are further sub-segmented into prime product category under each class. Hospitals and clinics, home healthcare, research and academia, and pharmaceuticals and biotechnology industry are the key end-users of medical gases.
Medical pure gases, particularly oxygen is the largest product segment in 2015, and it is anticipated that its dominance will prevail through the forecast period. The dominance of this segment is attributed to growing prevalence of respiratory conditions and wide use of oxygen in home care. Moreover, application of medical gases is perpetually growing in the emergency care, where admissions for respiratory emergency cases is on the rise. Wide use of pure gases and gas mixture in hospitals and clinical practice during treatment of various chronic diseases and surgical procedures is expected to support the demand for medical gas devices. Technological innovation in the field of medical devices will further add to the growth of medical gases devices in terms of replacement of obsolete equipment.
North America is observed to be the largest regional market for medical gases. Presence of developed healthcare infrastructure, favorable reimbursement systems and hoard for home healthcare for chronic respiratory disease management are the key drivers of North America market. Europe follows the lead of North America and the market growth of this region is attributed to untapped growth opportunities in Eastern Europe, growing focus of associations, regulatory bodies and welfare groups in increasing awareness about the benefits of home healthcare in long-term disease management. Rapid development of healthcare infrastructure, swift progress of medical tourism markets in emerging countries and growing awareness are the key growth facilitators in Asia-Pacific, Latin America, and Middle East and Africa medical gases market.
The overall medical gases market is witnessing growth in the number of collaborative strategies such as license agreements, joint ventures and M&A activities between the regional and international players. Air Liquide and Linde Gas are the largest players in this space.
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:

Global Bench-Top Dental Autoclaves Market is expanding at a CAGR of 7.5% from 2016 to 2022

According to the latest report published by Credence Research, Inc. “Bench-top Dental Autoclaves Market – (Device Type –Class N Autoclaves, Class B Autoclaves and Class S Autoclaves): Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  market was valued at USD 46.0 Mn in 2015, and is expected to reach USD 76.3 Mn by 2022, expanding at a CAGR of 7.5% from 2016 to 2022.
Market Insights
North America held the largest regional market, accounting for the market share of over 36% in 2015, and is expected to dominate the global bench-top dental autoclaves market during the forecast period of 2016 to 2022. Supportive government initiatives is the major factor the driving the bench-top dental autoclaves market in the region. Asia Pacific is expected to grow at the highest rate during the forecast period, due to rising number dentals laboratories in the region and rising awareness regarding the dental health in Asia Pacific.
Browse the full report Bench-top Dental Autoclaves: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/bench-Top-dental-autoclave-market
Among the device types, class B autoclaves are the dominating segment in terms of revenue due to due to the fact that it offers greater flexibility and is suitable for a wide range of setting. Moreover, class B autoclaves offer outstanding performance, unbeatable efficiency and the highest possible safety standards. The class S autoclaves is anticipated to be the fastest growing segment in the global bench-top autoclaves market as it’s an intermediate between the class N autoclaves and class S autoclaves. Moreover, user-friendly interface of the class N autoclaves would further drive the market in the forecast period.
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290

Posted by at No comments:

Global Medical Robotics Market To Reach Over US$ 20 Bn By 2023 – Credence Research

According to a new market research report published by Credence Research “Medical Robotics Market (Surgical Robots, Rehabilitation Robots, Non-invasive Radio surgery Robots, Hospital & Pharmacy Robots and Others) – Growth, Share, Opportunities, Competitive Analysis and Forecast 2016 – 2023”,the global medical roboticsmarket was valued at US$ 7.24 Bn in 2015 and is estimated to cross the US$ 20 Bn mark by 2023.
Market Insights
Medical robotic systems refer to robots used for various medical applications such as neurology, orthopedic, laparoscopy and others. These systems are designed for better precision, faster operation, minimized errors and reliability in medical applications. Since their first use in 1980s, the medical robots have undergone significant transformation so as to ensure proper treatment be provided to the patient. Consequently, medical robotics is triggering a paradigm shift in the overall medical sector. Governments of various countries including the U.S., Japan, China and other European countries are encouraging medical robotics by providing funding for further research. This acts as a significant factor fueling the market growth.
The medical robotics market has witnessed substantial growth in the past few years, majorly in North America. With the overall rise in adoption of automation systems across different application sectors, the medical robotics market is estimated to witness strong growth in the coming years. Market players are focused towards development of advanced robotic systems that can assist/perform medical surgeries without any human intervention. Due to rising penetration of minimally/non-invasive surgical procedures, the demand for medical robots is estimated to surge substantially during the forecast period.Thus, there can be seen a trend of hybrid operating room (OR) going hand-in-hand with medical robotics. Nevertheless, high initial costs of the systems may hamper the market growth significantly for the next few years.
Competitive Insights:
The global medical robotics market is highly competitive in nature with market players focusing on development of advanced robotic systems for the medical sector. The market is still in its emergent state and hence is driven by the development of different robots for the medical application. One of the most important concerns for the market is reliability of medical robots. Thus, medical robots vendors emphasize on improving the overall performance and patient safety. For better research and development in the field, market players also focus on getting funding from the national governments.
Key Trends:
  • Focus on research and development
  • Development of application-specific medical robots
  • Decline in the overall prices of overall robotic systems
  • Acquisition and mergers for expanding product portfolio and geographical presence
  • Proliferation of hybrid operating rooms coupled with medical robots
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com
Posted by at No comments:
Labels:

Tuesday, 4 October 2016

Actinic Keratosis Market is expected to reach USD 8,909.7 Mn by 2022, Credence Research

According to the latest report published by Credence Research, Inc. “Actinic Keratosis Market(Liquid Nitrogen Cryotherapy, Surgical Therapy, 5-aminolevulinic acid (ALA), Methyl Aminolevulinate (MAL), 5-fluorouracil, Imiquimod, Ingenol Mebutate, Diclofenac Sodium, Chemical Peels and Others) – Growth, Future Prospects and Competitive Analysis, 2016-2022,” the actinic keratosis market was valued at USD 6,561.8 Mn in 2015 and is expected to reach USD 8,909.7 Mn by 2022, with the market progressing at a CAGR 4.35%from 2016-2022.
Market Insights
Actinic keratosis (AK) is characterized by skin papules, macules or plaques resulting from prolonged exposure to harmful UV exposure and can result in squamous cell carcinoma. Risk of developing actinic keratosis increases with advancing age and is particularly higher in men as against women. About 5-20% of patients with actinic keratosis lesions develop malignant and potentially fatal squamous cell carcinomas.
Browse the full reportActinic Keratosis:Market Growth, Future Prospects and Competitive Analysis, 2016-2022report at http://www.credenceresearch.com/report/actinic-keratosis-market
Among the various treatment methods available, destructive therapies such as liquid nitrogen cryotherapy and surgical therapy constitute the gold standard for AK treatment. In 2015, cryotherapy was the most commonly sought treatment by clinicians. However, better clinical results of photodynamic therapy and growing preference for treatments based on drug-device combination have urged both caregivers and patients to opt for novel treatment methods that offer both advanced efficacy, aesthetic benefits and reduced risk of future malignancies.  Topical treatment is a prolonged treatment and comparatively more effective than other treatments but patient compliance is the key issue that hinders the growth of this segment. Photodynamic therapy is the fastest growing treatment throughout the forecast period due to rising demand for non-invasive surgeries, and less treatment sessions are the key factors expected to assist this market
North America is the largest market for actinic keratosis treatment due to growing prevalence of AK, better public awareness about occurrence of AK and associated risk of squamous cell carcinoma. According to American Academy of Dermatology (AAD), approximately 60% of the Americans aged 40 year or above, Actinic Keratosis is predisposed to develop having at least 1 AK lesion. Actinic keratosis is precursors of squamous cell cancer. U.S. held the largest share in the actinic keratosis market in 2015 owing to current prevalence of actinic keratosis in the region.Asia Pacific is the fastest growing market for AK treatments. Australia has the highest prevalence of actinic keratosis ranging between 40% to 60% in adult population. Growing awareness in the region and rapid development in healthcare infrastructure and healthcare expenditure are the key growth factors in Asia Pacific actinic keratosis market.
This market is majorly driven by wide presence of generic drugs and is moderately competitive. Photodynamic therapy market has developed a niche with methyl aminolevulinate and aminolevulinic acid drugs. Galderma and DUSA pharmaceuticals are the chief players in this space. Some of the major players in the global actinic keratosis market are Tolmar Pharmaceuticals, Inc, DUSA Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Aqua Pharmaceuticals, LLC, Galderma SA, Perrigo Company plc, LEO Laboratories, Apotex and others.
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com 
Ph: 1-800-361-8290
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)